Equity-Based Compensation | Note 13. Equity-Based Compensation On January 24, 2013, the Board of Directors of the Company adopted the 2013 Equity Incentive Plan (the “Plan”). In connection with the adoption of the Plan, 500,000 shares of common stock were reserved for issuance pursuant to the Plan, with automatic increases in such reserve available each year annually on January 1 from 2014 through 2023 equal to the lesser of 3.0% of the total outstanding shares of common stock as of December 31 of the immediately preceding year or, a number of shares of common stock determined by the Board of Directors, provided that the maximum number of shares authorized under the Plan will not exceed 1,992,241 shares, subject to certain adjustments. The maximum number of shares of common stock are currently reserved for issuance under the Plan Stock options and restricted stock issued by the Company under the Plan are generally subject to service conditions resulting in annual vesting on the anniversary of the date of grant over a period typically ranging between one and three years. Certain stock options and restricted stock issued by the Company under the Plan vest immediately upon issuance. Stock options issued by the Company under the Plan have contractual lives which expire over a period typically ranging between five and ten years from the date of grant subject to continued service to the Company by the participant . On February 7, 2018, the Compensation Committee of the Board of Directors of the Company adopted the 2018 Annual Incentive Program (the “Program”) as a subplan under the Plan. The Program provides an opportunity for performance-based compensation to senior executive officers of the Company, among others. The target annual incentive for each Program participant is expressed as a percentage of base salary and is conditioned on the achievement of certain financial goals (as approved by the Compensation Committee of the Board of Directors) or a combination of financial and non-financial goals. The Compensation Committee of the Board of Directors retains negative discretion over amounts payable under the Program. For 2018, the total target amount payable under the Program is approximately $1,423, with certain amounts to be settled with participants in cash, equity or a combination thereof. During the three and six months ended June 30, 2018, total compensation expense associated with the Program was approximately $163 and $305, respectively, split between cost of sales ($24 and $45, respectively), research and development ($47 and $90, respectively) and selling general and administrative expenses ($92 and $170, respectively) in the accompanying condensed statement of consolidated operations The following table summarizes the total equity-based compensation (benefit) expense recognized by the Company: Three Months Ended Six Months Ended June 30, June 30, 2018 2017 2018 2017 Equity-based compensation (benefit) expense recognized: Stock options $ (175 ) $ 133 $ 28 $ 476 Restricted stock 100 141 206 359 Other (a) 70 — 140 — Total equity-based compensation expense before income taxes (5 ) 274 374 835 Benefit for income taxes (b) — — — — Total equity-based compensation expense net of income taxes $ (5 ) $ 274 $ 374 $ 835 (a) Other represents expense associated with the Program and other employee contractual amounts to be settled in equity. (b) The benefit for income taxes from equity-based compensation for each of the periods presented has been determined to be $0 based on valuation allowances against net deferred tax assets. At June 30, 2018, total future compensation expense related to unvested awards yet to be recognized by the Company was approximately $228 for stock options and $284 for restricted stock. Total future compensation expense related to unvested awards yet to be recognized by the Company is expected to be recognized over a weighted-average remaining vesting period of approximately 1.2 years. During the six months ended June 30, 2018, the fair value of stock options granted was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions: March 16, 2018 Weighted average fair value per stock option $3.77 Volatility 62.58% Average risk-free interest rate 2.45% Dividend yield 0.00% Expected term (years) 3.3 During the six months ended June 30, 2017, the fair value of stock options granted was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions: February 10, 2017 Weighted average fair value per stock option $5.46 - $5.75 Volatility 62.89% - 63.75% Average risk-free interest rate 1.89% - 1.94% Dividend yield 0.00% Expected term (years) 5.0 - 5.5 For certain stock option awards, volatility is estimated based on the historical volatility of the Company when the expected term of the award is less than the period for which the Company has been publicly traded. For certain stock option awards, volatility is estimated based on the historical volatilities of certain peer group companies when the expected term of the award exceeds the period for which the Company has been publicly traded. The average risk-free rate is based on a weighted average yield curve of risk-free interest rates consistent with the expected term of the awards. Expected dividend yield is based on historical dividend data as well as future expectations. Expected term is calculated using the simplified method as the Company does not have sufficient historical exercise experience upon which to base an estimate. The activity for stock options was as follows: Six Months Ended June 30, 2018 2017 Number Options Weighted Weighted Average Grant Date Fair Value Number Options Weighted Weighted Average Grant Date Fair Value Outstanding at beginning of period 674,470 $ 11.58 $ 6.41 314,303 $ 15.62 $ 9.38 Stock options granted 24,000 $ 8.36 $ 3.77 44,000 $ 10.10 $ 5.51 Stock options exercised — $ — $ — — $ — $ — Stock options forfeited (133,835 ) $ 9.44 $ 5.15 (500 ) $ 15.74 $ 9.60 Stock options expired (28,000 ) $ 10.03 $ 5.19 (6,666 ) $ 17.43 $ 10.67 Outstanding at end of period 536,635 $ 12.05 $ 6.68 351,137 $ 15.04 $ 8.96 Stock options exercisable at end of period 396,627 $ 13.14 $ 7.53 226,471 $ 15.72 $ 9.43 Stock options expected to vest at end of period 140,008 $ 8.96 $ 4.29 124,666 $ 13.80 $ 8.11 At June 30, 2018, there was no intrinsic value associated with stock options exercisable or expected to vest. The weighted average remaining contractual term of stock options exercisable and expected to vest at June 30, 2018, was approximately 3.8 years and 5.0 years, respectively. There were no stock option exercises during the six months ended June 30, 2018 or 2017. The activity for restricted stock was as follows: Six Months Ended June 30, 2018 2017 Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Outstanding at beginning of period 52,502 $ 11.07 94,171 $ 14.29 Restricted stock granted 25,000 $ 8.21 30,000 $ 10.10 Restricted stock vested (25,000 ) $ 10.10 (28,834 ) $ 14.69 Restricted stock forfeited — $ — (11,667 ) $ 14.28 Outstanding at end of period 52,502 $ 10.17 83,670 $ 12.65 Restricted stock expected to vest at end of period 52,502 $ 10.17 83,670 $ 12.65 Restricted stock vesting during the six months ended June 30, 2018 and 2017, had a fair value of approximately $205 and $299, respectively. |